![Brigit Riley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Brigit Riley worked as Vice President at Sangamo Therapeutics, Inc. from 2014 to 2019 and as Chief Scientific Officer at Adverum Biotechnologies, Inc. from 2021 to 2024.
She completed her undergraduate degree at Northwestern University and her doctorate at the University of Minnesota.
Eerdere bekende functies van Brigit Riley
| Bedrijven | Functie | Einde |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Hoofd Techniek/Wetenschap/O&O | 29-01-2024 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01-09-2019 |
Opleiding van Brigit Riley
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
30
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
